Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults

Clinical trial NCT06863142 · RECRUITING

Trial details

NCT number: NCT06863142
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Influenza Prevention Seasonal Influenza

Start date: 2025-04-28
Primary completion: 2027-02-09
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.